{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:15:57Z","timestamp":1759497357934},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.eururo.2009.04.045","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T08:50:34Z","timestamp":1241772634000},"page":"145-153","source":"Crossref","is-referenced-by-count":29,"title":["Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study"],"prefix":"10.1016","volume":"57","author":[{"given":"Franti\u0161ek","family":"Z\u00e1t\u2019ura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"V\u0161eti\u010da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Abad\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Pavl\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schraml","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Brod\u2019\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Villoria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00e1","family":"Sust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2009.04.045_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2009.04.045_bib2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(06)67925-7","article-title":"Urinary incontinence in women","volume":"367","author":"Norton","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2009.04.045_bib4","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2165\/00003495-200363230-00003","article-title":"CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention","volume":"63","author":"Andersson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.eururo.2009.04.045_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2009.04.045_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1464-410X.2008.07769.x","article-title":"A review of adherence to drug therapy in patients with overactive bladder","volume":"102","author":"Basra","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.04.045_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0028-3908(00)00186-6","article-title":"The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats","volume":"40","author":"Ballet","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eururo.2009.04.045_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1185\/0300799009117014","article-title":"Dose response and safety of cizolirtine citrate (E-4018) in patients with pain following extraction of third molars","volume":"16","author":"Matthew","year":"2000","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.eururo.2009.04.045_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pain.2004.03.001","article-title":"Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies","volume":"110","author":"Aubel","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.eururo.2009.04.045_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2006.08.017","article-title":"Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy","volume":"52","author":"Aubel","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eururo.2009.04.045_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1358\/mf.2000.22.4.584453","article-title":"Pharmacology of cizolirtine: a new analgesic agent","volume":"22","author":"Alvarez","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.eururo.2009.04.045_bib12","first-page":"37","article-title":"Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder","volume":"77","author":"Smet","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.eururo.2009.04.045_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.eururo.2008.04.027","article-title":"Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study","volume":"56","author":"Mart\u00ednez-Garc\u00eda","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2009.04.045_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0022-5347(05)68951-3","article-title":"Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity","volume":"161","author":"Millard","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2008.06.080","article-title":"A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder","volume":"54","author":"Novara","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1464-410X.2003.03076.x","article-title":"Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder","volume":"91","author":"Mattiasson","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.04.045_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2006.10.005","article-title":"Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder","volume":"51","author":"Dmochowski","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2008.04.029","article-title":"Editorial comment on: cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study","volume":"56","author":"Lazzeri","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0306-4522(93)90252-B","article-title":"Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex","volume":"54","author":"Lecci","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.eururo.2009.04.045_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-5347(01)61835-4","article-title":"Involvement of spinal NK1 and opioids receptors in modulating the inhibitory effect of capsaicin on micturition reflex in the acute spinalized guinea pig","volume":"161","author":"Palea","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01268854","article-title":"Role of substance P in several models of bladder inflammation","volume":"25","author":"Luber-Narod","year":"1997","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2009.04.045_bib25","doi-asserted-by":"crossref","first-page":"F840","DOI":"10.1152\/ajprenal.00187.2002","article-title":"Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS","volume":"284","author":"Chien","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.eururo.2009.04.045_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1254\/jjp.86.165","article-title":"Effect of TAK-637, a tachykinin NK1-receptor antagonist, on lower urinary tract function in cats","volume":"86","author":"Kamo","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.eururo.2009.04.045_bib27","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0022-5347(01)67505-0","article-title":"Characterization of tachykinin NK2 receptors in human urinary bladder","volume":"153","author":"Zeng","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-5347(05)68047-0","article-title":"Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder","volume":"163","author":"Burcher","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.04.045_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/305143a0","article-title":"A VIP-containing system concentrated in the lumbosacral region of human spinal cord","volume":"305","author":"Anand","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2009.04.045_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1523\/JNEUROSCI.02-10-01369.1982","article-title":"The human spinal cord: substance P and methionine-enkephalin immunoreactivity","volume":"2","author":"de Lanerolle","year":"1982","journal-title":"J Neurosci"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809005028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809005028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T23:14:42Z","timestamp":1558307682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283809005028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0302283809005028"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2009.04.045","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}